Back
March 26, 2021
2 min. read

The Latest In Ophthalmology News: March 26, 2021

Medly

This month, we’re sharing the most recent top stories in ophthalmology news. New announcement on FDA approval on RayOne EMV was released, to extend a patient’s range of vision with a patented non-diffractive optic profile, enabling the depth of field of many presbyopia-correcting IOLs.

partner banner

In other headlines, telemedicine shows positive results of being the first line of patient diagnosis for further treatment in office. And exciting news on treating the first early-stage age-related macular degeneration (AMD) patient using the R:GEN laser, with further results to come through 2022 as they continue their clinical trial.

Read more on these stories below:

FDA Approves Rayner’s RayOne EMV IOL Eyewire, March 19, 2021

RayOne EMV extends a patient’s range of vision with a patented non-diffractive optic profile, enabling the depth of field of many presbyopia-correcting IOLs, but with reduced dysphotopsia, short neuroadaptation, reliable outcomes, high patient satisfaction, and improved affordability, according to Rayner.

Telemedicine eye care evaluations in early phase of pandemic well received Healio, March 23, 2021

Synchronous audiovisual telemedicine of eye care services was well received by patients and physicians during the first phase of the COVID-19 pandemic, according to a speaker at the virtual Wills Eye Conference. Physician evaluations showed that 86% felt they could make a therapeutic decision at a telemedicine appointment.

Retinal implants may help the blind see Ophthalmology Times, March 19, 2021

The system includes a camera embedded in the smart glasses, captures images in the wearer’s field of vision, and sends the data to a microcomputer placed in one of the eyeglasses’ end-pieces. The electrodes then stimulate the retina in such a way that the wearer sees a simplified, black-and-white version of the image.

Trial examining laser use in AMD treatment kicks off with first patient Ophthalmology Times, March 9, 2021

Lutronic Vision has treated the first early-stage age-related macular degeneration (AMD) patient in its clinical trial evaluating the R:GEN laser.

Newly formed Ophthalmology Foundation to support global ophthalmic education Healio, March 17, 2021

The Ophthalmology Foundation, a nonprofit successor organization of the International Council of Ophthalmology Foundation, will provide educational programs and fellowships globally, according to a press release.

Want to keep updated with Medly? Subscribe to our monthly newsletter!

UTM Source:UTM Campaign:UTM Content:UTM Medium:UTM Term:UTM Device:Landing Page:Company:Last Name:
Join Medly
Partner with Medly
Live Chat